Efficacy of Zidovudine Compared to Stavudine, Both in Combination with Lamivudine and Indinavir, in Human Immunodeficiency Virus-Infected Nucleoside-Experienced Patients with No Prior Exposure to Lamivudine, Stavudine, or Protease Inhibitors (Novavir Trial)

We compared the efficacy and the toxicity of zidovudine (AZT) versus stavudine (d4T), in combination with lamivudine (3TC) and indinavir, in AZT-, dideoxyinosine (ddI)-, and/or dideoxycytosine (ddC)-experienced patients in a randomized comparative multicenter trial. One hundred seventy human immunod...

Descripción completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Autores principales:	Joly, Véronique, Flandre, Philippe, Meiffredy, Vincent, Brun-Vezinet, Françoise, Gastaut, Jean-Albert, Goujard, Cécile, Remy, Gérard, Descamps, Diane, Ruffault, Annick, Certain, Agnès, Aboulker, Jean-Pierre, Yeni for the Novavir Study Group, Patrick
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	American Society for Microbiology (ASM) 2002
Materias:	Antiviral Agents
Acceso en línea:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127263/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12019107/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.6.1906-1913.2002
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!